Navigation Links
OxThera coordonne le projet Elimox du 7e PC - 2,19 millions EUR dédiés au développement d'un médicament pour traiter l'hyperoxalurie
Date:9/24/2013

STOCKHOLM, September 24, 2013 /PRNewswire/ --

OxThera AB a annoncé aujourd'hui être le coordinateur d'un nouveau projet européen, Elimox, planifié sur 2 ans et financé par le 7e PC à hauteur de 2,19 millions EUR. L'objectif principal de ce projet est le développement d'un médicament pharmaceutique bactérien innovant et unique, destiné au traitement d'une maladie héréditaire grave et invalidante : l'hyperoxalurie primaire.

« Nous sommes extrêmement heureux d'obtenir cette contribution au développement d'un traitement de l'hyperoxalurie primaire », a expliqué Elisabeth Lindner, coordonnatrice du projet Elimox et PDG d'OxThera. « Les résultats de recherche issus de ce projet permettront d'apporter des connaissances approfondies sur l'impact des traitements pharmaceutiques probiotiques et de leur rôle ultérieur en matière de santé et de maladie », a poursuivi Mme Lindner.

Le projet Elimox comprendra le développement de médicaments bactériens, l'élaboration de méthodes d'analyse et un développement clinique concernant l'hyperoxalurie primaire. Il a été démontré que la bactérie Oxalobacter formigenes favorise activement l'élimination entérique d'oxalate sur des sujets animaux (Hatch, 2011 et 2013). Les premières études cliniques exploratoires évaluant une formulation initiale des bactéries ont montré une baisse importante de l'excrétion urinaire d'oxalate chez les sujets atteints d'hyperoxalurie primaire (Hoppe, 2006).

À propos du projet Elimox

Le projet Elimox est financé dans le cadre du programme « 
'/>"/>

SOURCE OxThera
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OxThera stärker patentportfölj för särläkemedel - Primär hyperoxaluri
2. OxThera stärkt sein Patentportfolio für primäre Hyperoxalurie, eine seltene Krankheit
3. OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria
4. Bausch + Lomb soumet une déclaration denregistrement pour un projet doffre publique initiale
5. New Vision Hope For Millions Undergoing Cataract Surgery
6. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
7. Philips ermöglicht noch besseren Zugang zu Behandlungen für häufige Todesursache in den USA durch Bereitstellung seines einmillionsten AED
8. Info Graphic: Middle managers are frozen by information overload, costing companies millions
9. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
10. Millions Around the World to Have Access to Low-Cost HIV Test by 2013
11. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)...  Olympus, a precision technology leader in designing and ... other core businesses, announced today the opening of its ... MN. The new medical device research & ... company for continued long-term growth in the surgical sector. ... on April 27 and was attended by Mark ...
(Date:4/28/2015)... 28, 2015  Securities lawyers at Dunnam & ... ANGO ). Concerned ANGO investors who purchased between ... to contact securities attorney Hamilton Lindley by clicking ... 9, 2015, a quarterly loss of $4.3 million and ... year to a range of $356 million to $360 ...
(Date:4/28/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( http://www.oramed.com ... I am very excited to announce that we are on ... for oral insulin (ORMD-0801) and the treatment of type 2 ... coming weeks. This clinical trial will be our largest and most ... the company, literally putting us in a different place. ...
Breaking Medicine Technology:Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 2Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 3
... KineMed Inc., a,pathway-based drug discovery and development ... of an investigational agent,to regenerate nerve cells in ... cognition and mood. The agent, part of a ... a behavioral test in a,preclinical model. The findings ...
... am ET, BEDMINSTER, N.J., Oct. 11 ... top-line results from,the company,s Phase 3 study of ... 83 patients with short bowel,syndrome (SBS) received either ... dose (0.10 mg/kg/day) or placebo. The,clinical efficacy endpoint ...
Cached Medicine Technology:KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
(Date:4/28/2015)... 28, 2015 The popular all-natural supplement ... for their newly launched L-Style Revolution Program™, and collectively ... counting in just two short months. The customized ... exercise plan for men and women of all health ... loss and weight maintenance goals faster than traditional methods. ...
(Date:4/28/2015)... MSA Executive Search , an INTEGRATED ... that it has been retained to lead a nationwide ... for The Queen's Health Systems (QHS) located in ... & CEO Arthur A. Ushijima, the Executive Vice President ... the Queen’s Medical Center Punchbowl and West O’ahu sites, ...
(Date:4/28/2015)... PA (PRWEB) April 28, 2015 An ... Blair A. Jobe, MD, FACS , has launched ... esophageal tissue with extracellular matrix (ECM) can help patients ... form of esophageal cancer. , ECM is a complex ... cell attachment and migration and signals that guide cell ...
(Date:4/28/2015)... New and more complex medicines ... manufacturers, payers, pharmacists and patients. Now Specialty Pharmacy ... partnering with the National Association of Specialty Pharmacy ... to this developing field to better equip pharmacy ... , “This partnership creates a powerful platform for ...
(Date:4/28/2015)... Chicago, IL (PRWEB) April 28, 2015 ... enhance its research and healthcare services programs, the ... Orlando, Ph.D. Orlando comes to MDA from Fidelity ... oversaw funding of research projects in neurodegenerative diseases ... scientific conferences. Prior to her time at Fidelity, ...
Breaking Medicine News(10 mins):Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3
... , , , REDMOND, ... meeting that seeks solely to personally enlighten and transform the people ... annual meeting under the vision of Chairman and CEO Dwayne ... memory care communities, Aegis Living is in the business of taking ...
... , WASHINGTON , Jan. ... announced that it has filed a motion for immediate relief ... Georgia from the imminent and serious threat of ... late yesterday, seeks appointment of a monitor who will set ...
... online resources, coping tips , FRIDAY, Jan. 29 (HealthDay ... for 75 percent of adult cancer patients, according to ... , Breakthrough cancer pain refers to sudden, temporary flares ... is taking pain medication. , "We,re not talking about ...
... when caught early. But in a third of cases, ... when cure is much less likely. , Quicker identification ... mathematical model developed by researchers at the Ohio State ... Richard J. Solove Research Institute., The model uses information ...
... Association of Physicists in Medicine (AAPM) has issued a statement ... New York Times yesterday and earlier in the week that ... last decade involving people undergoing radiation therapy. While it ... the statement acknowledges their gravity. It reads in part: "The ...
... 2010 Investigators from the International Center for Biomedicine ... Center for Bioinformatics of the Universidad de Talca, have ... astemizole, may be suitable for use as PET (positron ... detection of Alzheimer,s Disease. The study is published in ...
Cached Medicine News:Health News:Aegis Living's CEO Transforms Business As Usual One Employee At a Time 2Health News:Aegis Living's CEO Transforms Business As Usual One Employee At a Time 3Health News:Justice Department Files for Immediate Relief Regarding Conditions in Georgia's Hospitals 2Health News:Justice Department Files for Immediate Relief Regarding Conditions in Georgia's Hospitals 3Health News:Justice Department Files for Immediate Relief Regarding Conditions in Georgia's Hospitals 4Health News:Three-Fourths of Cancer Patients Have Severe Flares of Pain 2Health News:Three-Fourths of Cancer Patients Have Severe Flares of Pain 3Health News:Curing more cervical cancer cases may be in the math 2Health News:AAPM statement on quality radiation therapy 2Health News:Promising new neuroimaging techniques for early detection of Alzheimer's disease 2
... continue the outstanding worldwide ... microscopes in medical and ... UIS infinity-corrected optics. The ... performance and even greater ...
... Coolscope operates with a simple click ... display. Direct the mouse cursor to ... image of the slide and the ... intuitive Graphic User Interface (GUI) enables ...
... Eclipse TS100 is an innovative ... This high quality tool complements ... and increased stability - Nikon ... vibration resistant design that greatly ...
Carbide drill bits, cutters, side cutting. Available in various sizes....
Medicine Products: